Versarien Secures Funding for In-House Testing Expansion
Company Announcements

Versarien Secures Funding for In-House Testing Expansion

Versarien (GB:VRS) has released an update.

Versarien PLC has successfully raised £550,000 through a share placement of over 846 million new ordinary shares at 0.065 pence each. The funds are earmarked for the purchase of in-house concrete and mortar testing equipment to aid in the development of CementeneTM admixture for BS934 accreditation and general corporate purposes. This strategic move is intended to enhance Versarien’s testing capabilities, offering cost savings and supporting the company’s expansion in the construction and leisure sectors.

For further insights into GB:VRS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskVersarien Faces Delay in Employment Tribunal
TipRanks UK Auto-Generated NewsdeskVersarien Bolsters Stake in Gnanomat for Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!